MC heads into the back half of July with short sellers retreating, options traders heavily bullish, and a Q2 earnings print just landed — yet the stock is quietly underperforming the advisory peer group that has rallied sharply this week.
The most striking divergence is in options. Call demand has overwhelmed put activity, pushing the put/call ratio to 0.29 — more than 1.3 standard deviations below its 20-day average of 0.33 and near the low end of the past year's range. That's an unusually one-sided tilt toward upside positioning. The shift has been abrupt: the PCR ran in the 0.34–0.36 range through most of early July before collapsing to sub-0.29 over the past week, almost certainly reflecting activity tied to the Q2 earnings release on July 29. Short interest meanwhile has eased by about 2.7% over the past week to 5.6% of the free float — not dramatically low, but moving in the right direction for longs. Borrow conditions remain comfortable: availability is wide at 644% of current short interest (up meaningfully on the week), and cost to borrow is running at just 0.44%, a low absolute level despite a modest one-month uptick.
The Street is cautious rather than outright bearish, but the most recent analyst moves have applied downward pressure on targets. UBS downgraded MC to Sell on July 8, raising its target marginally to $60 while stepping off a prior Neutral — the only recent directional action of note. Keefe, Bruyette & Woods trimmed its target to $66 on July 10 while keeping a Market Perform. With the stock now at $68.59, it is already trading above both of those targets. Morgan Stanley remains the outlier bull, last citing an Overweight with an $83 target, though that was set in April. The consensus mean sits at $71.50, implying modest upside from current levels. The factor scores reflect this ambivalence: EPS surprise ranks at the 57th percentile — decent but not compelling — forward earnings growth ranks in just the 33rd, and the short score at the 25th percentile flags that short-side pressure is well below the peer median. Dividend scoring, at the 88th percentile, remains a relative standout.
Where the picture gets interesting is peer comparison. Advisory peers have had a strong week. HLI gained 4.0% on the week and SF surged 9.1%. PJT added 3.8%. MC by contrast rose just 1.1%. EVR and LAZ were roughly flat or slightly down, so the laggard story isn't universal — but MC's Q2 print, which featured record new business origination and a revenue beat of roughly 3% at $307 million, hasn't generated the kind of relative lift the bull case would imply. Institutional positioning offers some context: BlackRock added over 241,000 shares as of June 30 to hold 11.8% of the company, and Wasatch Advisors added roughly 114,000 shares in the same period. Those are constructive signals from active holders.
The Q2 earnings report filed this week removes the near-term catalyst overhang, but Q1's history is worth noting: the stock fell 6.6% the day after that print and was down 8.5% five days later. With no next earnings date yet confirmed, the key watch point is how deal momentum in the record pipeline translates into Q3 fee revenue — and whether the advisory group's broader weekly outperformance begins to close the gap with MC's more cautious positioning.
See the live data behind this article on ORTEX.
Open MC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
